Torrent Pharma launches First and Only Generic Version of Keveyis® (dichlorphenamide) Tablets in the United States
BASKING RIDGE, N.J., April 6, 2023 /PRNewswire/ -- Torrent Pharma has begun shipping the generic version of Xeris's Keveyis® (dichlorphenamide), 50mg tablets, following final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application. Torrent is distributing the product through select specialty pharmacies beginning this month.
Dichlorphenamide Tablets are indicated for the treatment of primary hyperkalemic periodic paralysis and related variants.
Primary periodic paralysis (PPP) is a rare condition that causes sudden episodes that affect the muscles, resulting in extreme muscle weakness or temporary paralysis ? most often the inability to move the muscles of the arms and legs.
About Torrent Pharma Inc.
Torrent Pharma Inc., a wholly owned subsidiary of Torrent Pharmaceuticals Limited is a leading pharmaceutical company with headquarters in India.
To mark National Hospice Palliative Care Week, the Quebec Coalition for Palliative Care Access (the Coalition) is proud to celebrate the positive impact of palliative care on the well-being of people with life-limiting illness.
Palliative care is...
A native born and trained Brazilian oncologist is in the forefront of a new era in the treatment of cancer patients with cutting edge proton therapy medical technology developed in Israel by P-Cure.
"It is my dream to be able to bring the P-Cure...
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...
Women's Heart Health Month is recognized every May and is focused on raising awareness about cardiovascular health among women. It aims to educate women about the risks, symptoms, and prevention of heart disease, which is the leading cause of death...
RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy.
The focus of the collaboration is to...
